Kuros is engaged in the development of orthobiologics and sealant products for tissue repair and regeneration... Read more
Kuros is engaged in the development of orthobiologics and sealant products for tissue repair and regeneration... Read more
News
May 08, 2023
FinanzNachrichten
Kuros Biosciences AG: Adhoc: Kuros Biosciences AG: Annual General Meeting of Kuros Biosciences approves all resolutions
Feb 21, 2023
MarketScreener
Kuros Biosciences AG: Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
Jun 08, 2022
Markets Insider
Kuros Biosciences AG: Annual General Meeting of Kuros Biosciences approves all resolutions
Apr 27, 2022
MarketScreener
Kuros Biosciences AG: Kuros Biosciences : Press Release, 27 April 2022
Apr 27, 2022
Markets Insider
Kuros Biosciences AG: Kuros Biosciences continues strong commercial roll-out of MagnetOs bone graft
Apr 21, 2022
FinanzNachrichten
Kuros Biosciences AG: EQS-Adhoc: Kuros Biosciences AG: Kuros Biosciences's MagnetOs Flex Matrix Cleared by FDA for Spinal Indications
Jan 30, 2020
StreetInsider
Press Release: Kuros : Kuros Reports Publication of MagnetOs Preclinical Data Demonstrating Superiority to Market-Leading Synthetic Bone Grafts in Spinal Fusion
Dec 14, 2019
BioPortfolio
Kuros: Kuros Biosciences AG KURN Financial and Strategic SWOT Analysis Review Published by Global Data Prices from USD $106
Dec 06, 2019
startupticker
Kuros: Kuros raises CHF12.5 million
Oct 29, 2019
MarketScreener
Kuros: Kuros convenes Extraordinary General Meeting
Kuros Biosciences AG Competitors
1
2
3
4
5
6
7
8
9
10